Researchers will study the frequency of, and risk factors for, cancer in golden retrievers, using data from the Golden Retriever Lifetime Study and VetCompass health databases.

Researchers will evaluate proactive treatments for recurrent ear infections as well as a novel treatment for active ear infections.

Researchers will develop new training strategies for working dogs using non-food items to reward performance to help reduce overweight/obesity issues and resulting health issues in these animals.

Researchers will conduct a clinical trial evaluating the effectiveness of a novel treatment to clear ear infections in dogs.

Researchers will evaluate nine currently available drugs for the treatment of deadly algae infections in dogs.

Researchers will study antibiotic resistance in dogs with recurrent urinary tract infections caused by E. coli, as well as gut microbiota responses to antibiotics in dogs with and without multidrug-resistant e. coli strains, to help inform antibiotic use.

Researchers will study how to block an immune protein associated with the accelerated spread of osteosarcoma in dogs.

Researchers will evaluate the safety and efficacy of a novel combination of checkpoint inhibitor and adoptive T-cell therapy in giant-breed dogs diagnosed with appendicular osteosarcoma, a type of primary bone cancer of the limbs.

Using genotyping data from the Golden Retriever Lifetime Study, researchers will conduct a study to help identify genomic regions involved with increased susceptibility for hemangiosarcoma in American golden retrievers.

Researchers will study the health and well-being of service dogs paired with military veterans with post-traumatic stress disorders. They will use their findings to inform new tools to assess and track the well-being of these specially trained dogs.